• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Anti-thymocyte Globulin (Rabbit), Thymoglobulin

Testing conducted after shipping found that the lot exceeded a potency specification which has the potential to cause prolonged neutropenia. This product is indicated for the treatment of renal transplant acute rejection in conjunction with concomitant immunosuppression.

[August 9, 2000 - Letter - SangStat Medical Corp.]